Oxford jab offers less S Africa variant protection
February 8, 2021 6:29 am
Oxford-AstraZeneca’s vaccine offers “minimal protection” against mild disease from the South Africa variant, scientists say early trials suggest.
A new study, not yet peer reviewed, involved about 2,000 people who were on average 31 years old.
But Prof Sarah Gilbert, Oxford lead vaccine developer, said vaccines should still protect against severe disease.
She said developers were likely to have a modified Oxford jab by the autumn to combat the South Africa variant.
Meanwhile, vaccine minister Nadhim Zahawi told the BBC’s Andrew Marr that a booster in the autumn and annual vaccines could be required to combat variants.
More than 100 cases of the South Africa variant have been found in the UK.